RecallDepth
Class II Terminated

Amoxicillin for Oral Suspension USP, 400 mg/ 5 mL, 50 mL bottle, Rx only, Manufactured In Canada by: Teva Canada Limited, Toronto, Canada, NDC 0093-4161-76

This recall has been terminated (originally issued August 31, 2016).

Company
Teva North America
Recall Initiated
June 24, 2016
Posted
August 31, 2016
Recall Number
D-1470-2016
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
53,328 bottles
Firm Location
Horsham, PA, United States
Official Source
View on FDA website ↗

Reason for Recall

Superpotent drug: Out of specification test result for assay during stability testing.

Distribution

Nationwide

Lot / Code Info

Lot # 35434158A, Exp 6/17

More recalls by Teva North America

View all recalls by this company →

Other recent Class II Drug recalls